company background image
A041960 logo

Komipharm International KOSDAQ:A041960 Stock Report

Last Price

₩4.18k

Market Cap

₩292.9b

7D

0.7%

1Y

-38.5%

Updated

26 Apr, 2024

Data

Company Financials

Komipharm International Co., Ltd.

KOSDAQ:A041960 Stock Report

Market Cap: ₩292.9b

A041960 Stock Overview

Komipharm International Co., Ltd. manufactures and sells veterinary vaccines, veterinary pharmaceuticals and disinfectants, and bio-fertilizers internationally.

A041960 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for A041960 from our risk checks.

Komipharm International Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Komipharm International
Historical stock prices
Current Share Price₩4,175.00
52 Week High₩7,649.75
52 Week Low₩3,735.00
Beta-0.41
1 Month Change-14.71%
3 Month Change-7.22%
1 Year Change-38.48%
3 Year Change-55.60%
5 Year Change-76.38%
Change since IPO313.89%

Recent News & Updates

Is Komipharm International (KOSDAQ:041960) A Risky Investment?

Mar 27
Is Komipharm International (KOSDAQ:041960) A Risky Investment?

Recent updates

Is Komipharm International (KOSDAQ:041960) A Risky Investment?

Mar 27
Is Komipharm International (KOSDAQ:041960) A Risky Investment?

A Look At Komipharm International's (KOSDAQ:041960) Share Price Returns

Feb 26
A Look At Komipharm International's (KOSDAQ:041960) Share Price Returns

Is Komipharm International Co., Ltd.'s (KOSDAQ:041960) Shareholder Ownership Skewed Towards Insiders?

Jan 22
Is Komipharm International Co., Ltd.'s (KOSDAQ:041960) Shareholder Ownership Skewed Towards Insiders?

Komipharm International (KOSDAQ:041960) Is Carrying A Fair Bit Of Debt

Dec 18
Komipharm International (KOSDAQ:041960) Is Carrying A Fair Bit Of Debt

Shareholder Returns

A041960KR PharmaceuticalsKR Market
7D0.7%2.5%2.2%
1Y-38.5%6.7%5.4%

Return vs Industry: A041960 underperformed the KR Pharmaceuticals industry which returned 7.1% over the past year.

Return vs Market: A041960 underperformed the KR Market which returned 4.5% over the past year.

Price Volatility

Is A041960's price volatile compared to industry and market?
A041960 volatility
A041960 Average Weekly Movement4.9%
Pharmaceuticals Industry Average Movement4.6%
Market Average Movement5.2%
10% most volatile stocks in KR Market11.7%
10% least volatile stocks in KR Market2.4%

Stable Share Price: A041960 has not had significant price volatility in the past 3 months.

Volatility Over Time: A041960's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1972147Seong-Cheol Moonwww.komipharm.co.kr

Komipharm International Co., Ltd. manufactures and sells veterinary vaccines, veterinary pharmaceuticals and disinfectants, and bio-fertilizers internationally. The company manufactures veterinary drugs in injectable, powder, oral solution, topical solution, disinfectant, and other forms. It is also developing anticancer drugs and cancer pain-relieving agents for human health and life.

Komipharm International Co., Ltd. Fundamentals Summary

How do Komipharm International's earnings and revenue compare to its market cap?
A041960 fundamental statistics
Market cap₩292.89b
Earnings (TTM)-₩3.98b
Revenue (TTM)₩42.65b

6.9x

P/S Ratio

-73.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A041960 income statement (TTM)
Revenue₩42.65b
Cost of Revenue₩30.12b
Gross Profit₩12.53b
Other Expenses₩16.51b
Earnings-₩3.98b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-56.72
Gross Margin29.37%
Net Profit Margin-9.33%
Debt/Equity Ratio74.3%

How did A041960 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.